Adrenomedullin, a novel target for neurodegenerative diseases
Keywords: 
Adrenomedullin
Neurodegenerative diseases
Cytoskeleton
Alzheimer’s disease
Vascular dementia
Issue Date: 
2018
ISSN: 
0893-7648
Citation: 
Ferrero-Hidalgo, H. (Hilda). "Adrenomedullin, a novel target for neurodegenerative diseases". Molecular Neurobiology. 2018 (55), 2018, 8799 - 8814
Abstract
Neurodegenerative diseases represent a heterogeneous group of disorders whose common characteristic is the progressive degeneration of neuronal structure and function. Although much knowledge has been accumulated on the pathophysiology of neurodegenerative diseases over the years, more efforts are needed to understand the processes that underlie these diseases and hence to propose new treatments. Adrenomedullin (AM) is a multifunctional peptide involved in vasodilation, hormone secretion, antimicrobial defense, cellular growth, and angiogenesis. In neurons, AM and related peptides are associated with some structural and functional cytoskeletal proteins that interfere with microtubule dynamics. Furthermore, AM may intervene in neuronal dysfunction through other mechanisms such as immune and inflammatory response, apoptosis, or calcium dyshomeostasis. Alterations in AM expression have been described in neurodegenerative processes such as Alzheimer’s disease or vascular dementia. This review addresses the current state of knowledge on AM and its possible implication in neurodegenerative diseases.

Files in This Item:
File
s12035-018-1031-y.pdf
Description
Size
1.03 MB
Format
Adobe PDF


Statistics and impact

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.